Baseline and follow-up SF-36 scores in patients who achieved hematologic CR and those who did not. Hematologic responses were determined at 1 year after treatment. (A) Mean SF-36 scores for patients who achieved hematologic CR at baseline (gray squares, n = 57), at 1 year after treatment (light gray triangles, n = 41), and at 2 years after treatment (gray diamonds, n = 36). (B) Mean SF-36 scores for patients who did not achieve hematologic CR at baseline (gray squares, n = 88), 1 year after treatment (light gray triangles, n = 63), and 2 years after treatment (gray diamonds, n = 48). As can be seen, patients who achieved a hematologic CR at 1 year progressively improved and equaled age-matched U.S. population norms (black circles) at 2 years, whereas those patients who did not achieve hematologic CR improved from baseline to the 1 year follow-up evaluation, and that improvement was maintained but not exceeded over the second year after treatment. Those means that are significantly (P < .05) below age-matched US population norms are underlined. The numeric mean scores and P values are provided in Tables S3 and S4.